RxDoctor Payments Data

Chelsea Vance, APRN

Nurse Practitioner · Dixon, KYNPI 1043964927

Payments from drug & device makers

$1,686in general payments, 2019–2025

Across 113 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$423
  • Corium, LLC$351
  • Novo Nordisk$133
  • Lilly USA, LLC$91
  • Axsome Therapeutics, Inc.$90
  • GSK$69
  • plus $528 from 18 others

What the payments were for

  • Food & beverage$1,686100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,686 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,032
Medicare patients
58
Services billed
76

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide17$24,987
OzempicSemaglutide24$24,397
MounjaroTirzepatide14$19,014
FarxigaDapagliflozin Propanediol24$15,782
EliquisApixaban11$7,495
LinzessLinaclotide11$5,454
Rivastigmine11$3,027
Divalproex Sodium27$3,023
SynthroidLevothyroxine Sodium21$1,502
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$852
Atorvastatin Calcium84$739
Memantine Hcl33$706
Metoprolol Succinate34$626
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide23$614
Losartan Potassium55$569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$91$44,00231 claims
Novo NordiskOzempic$133$24,39724 claims
AstraZenecaFarxiga$61$15,78224 claims
PfizerEliquis$16$7,49511 claims
AbbVieLinzess, Synthroid$423$6,95632 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Dixon

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →